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Summary 
Aspergillus fumigatus is an opportunistic fungal pathogen that typically infects the lungs of 
immunocompromised patients leading to a high mortality. H-ficolin, an innate immune 
opsonin, is produced by type II alveolar epithelial cells and could participate in lung defences 
against infections. 
Here, we utilised the human type II alveolar epithelial cell line, A549, to determine the 
involvement of H-ficolin in fungal defence. Additionally, we investigated the presence of H-
ficolin in bronchoalveolar lavage fluid (BAL) from transplant patients during pneumonia. 
 
H-ficolin exhibited demonstrable binding to A. fumigatus conidia via L-fucose, D-mannose 
and N-acetylglucosamine residues in a calcium- and pH-dependent manner. Moreover, 
recognition led to lectin complement pathway activation and enhanced fungal association 
with A549 cells. Following recognition, H-ficolin opsonization manifested an increase in IL-
8 production from A549 cells which involved activation of the intracellular signalling 
pathways MEK 1/2, p38 MAPK and JNK. Finally, H-ficolin concentrations were 
significantly higher in BAL of patients with lung infections compared to control subjects 
(n=16; p=0.00726). ROC curve analysis further highlighted the potential of H-ficolin as a 
diagnostic marker for lung infection (AUC=0.77; p<0.0001). 
Thus, H-ficolin participates in A. fumigatus defence via activation of the lectin complement 
pathway, enhanced fungal-host interactions and modulated immune responses. 
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Introduction 
Aspergillus fumigatus (A. fumigatus) is the most common mould pathogen in the developed 
world and is the primary causative species of the potentially fatal, invasive aspergillosis (IA) 
in immunocompromised patients. IA is an increasing problem due to the emergence of a 
number of antifungal resistant strains and even if treated effectively, harbours an infection 
associated mortality rate between 30-80% 1, 2. Transplant patients are at particular risk and it 
is estimated that up to 1 in 4 lung or heart transplant patients will succumb to this infection 3. 
IA is propagated via the inhalation of small hydrophobic spores (conidia) which penetrate 
deep into the alveolar space where they germinate, invading the vasculature and disseminate 
to other organs such as the brain and skin 4, 5. A. fumigatus can be found ubiquitously and is 
mostly omnipresent, making inhalation difficult to avoid. Fortunately, a functional innate 
immune system can provide robust and effective responses to aid the removal of spores. The 
initial defence to the inhalation of A. fumigatus is mucociliary clearance but if this is evaded 
then an innate immune response comprising of type II pneumocytes, alveolar macrophages, 
neutrophils and serum pathogen recognising opsonins, can work synergistically to potentiate 
conidia recognition and removal 6. One such family of opsonins are coined ficolins.  
 
Ficolins are recently discovered serum opsonins with functions comparable to the widely 
studied collectins, mannose-binding lectin (MBL) and the surfactant proteins (SP). They are 
composed of two key domains; an N-terminal collagen-like domain and a C-terminal 
fibrinogen-like (FBG) domain with lectin activity highly specific for the acetylated 
carbohydrate, N-acetylglucosamine (GlcNAc), a key component of the A. fumigatus cell wall 
7
. Humans possess three types of ficolin; the membrane-bound M-ficolin and the serum types, 
L- and H-ficolin. Ficolins primarily function as opsonins whereby they can enhance the 
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phagocytosis of pathogenic microorganisms but they are also capable of activating the lectin 
complement pathway via association with MBL associated serine protease (MASP)-2 8, 9. 
Novel immunomodulatory functions are also beginning to arise but mechanistic insights into 
these are in their infant stages 10-13.  
 
Of the serum ficolins, H-ficolin is undoubtedly the most poorly understood, with the fewest 
pathogenic targets and a distinct lack of characterisation in comparison to L-ficolin. We have 
recently indicated that the other serum ficolins (L-ficolin and its rodent orthologue, ficolin-A) 
are capable of enhancing host-pathogen interactions within the fungal airway immunity 10, 14. 
Whereas L-ficolin is not produced in the lung, H-ficolin can be secreted directly by resident 
type II epithelial cells 15. In addition, previous observations have indicated that H-ficolin 
could recognise A. fumigatus conidia but this interaction was not characterised in any detail 
16
.  
 
Therefore, we investigated whether opsonization of A. fumigatus by H-ficolin could 
potentiate the functions of A549 cells, a cell line with characteristics of type II epithelial cells 
17
. Additionally, we investigated the role of H-ficolin in lectin complement pathway 
activation, cytokine modulation and we measured the H-ficolin concentrations in the 
bronchoalveolar lavage (BAL) of lung transplant patients with, or without post-transplant 
infection.  
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Materials and Methods 
Ethical approval and patient consent 
Bronchoalveolar lavage sampling of lung transplant patients from the Royal Brompton and 
Harefield NHS Foundation Trust was performed under Biomedical Research Unit ethics 
approval (RBH/AS1).  
 
Fungal pathogens 
A clinical isolate of A. fumigatus, obtained from an invasive aspergillosis patient at the 
Norfolk and Norwich University NHS Foundation Trust (as used in 14, 18), was subcultured on 
Sabouraud dextrose agar at 37°C for 7 days, and conidia were harvested using sterile 
physiological saline (Oxoid). Resting live conidia were used immediately or fixed in 4% 
phosphate-buffered saline (PBS)–formaldehyde for 10 min at room temperature (RT), 
washed, and resuspended in PBS. Fixed A. fumigatus. conidia were stored at 4°C for up to 1 
month until further use. 
 
Cells and reagents 
All experiments were conducted using the A549 adenocarcinomic human alveolar basal 
epithelial cell line as a model for type II alveolar epithelial cells. A549 cells were maintained 
in RPMI-1640 supplemented with 10% heat-inactivated foetal calf serum and 50 I.U mL-1 
penicillin and 50 µg mL-1 streptomycin. Experiments were all performed in serum-free 
conditions. Recombinant H-ficolin was purchased from R&D Systems.  FITC was purchased 
from Sigma-Aldrich. The MEK 1/2 inhibitor (U0126), p38 MAPK inhibitor (SB202190) and 
the JNK inhibitor (SP600125) were purchased from Tocris Biosciences.  
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Detection of infection and H-ficolin in bronchoalveolar lavage 
BAL fluid was collected from lung transplant recipients at Royal Brompton and Harefield 
NHS Foundation Trust by instilling 200 mL sterile saline into distal airway segments under 
flexible bronchoscopy. BAL return was centrifuged at 200 g for 10 min. Supernatant was 
subsequently analyzed via the lateral-flow device for Aspergillus antigens, indicative of 
invasive aspergillosis, as previously described 19 and/or via detection of galactomannan (GM) 
using a Platelia™ Aspergillus antigen kit (Bio-Rad). For BAL samples, an index of < 0.5 was 
considered negative, an index of ≥ 0.5 was considered positive for GM 20. Samples were 
tested for a panel of respiratory viruses (multiplex PCR) and bacteria by culture (B57, UK 
standard for microbiology investigations) 21. High resolution computed tomography (HRCT) 
chest imaging was reviewed for evidence of findings consistent with fungal infection 21. The 
presence of H-ficolin in the BAL fluid of lung transplant patients was detected using a 
ficolin-3 human ELISA kit (Hycult). Patients were categorised for possible, probable and 
proven invasive fungal infection according to revised European Organization for Research 
and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National 
Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) criteria 22. 
 
Fluorescent microscopy 
To detect the presence of intracellular H-ficolin in A549 cells, A549 cells were grown in 8-
well chamber Permanox slides (Lab-Tek). Following growth, cells were permeabilised with 
PBS containing 0.1% Tween-20 prior to staining with primary monoclonal anti-H-ficolin 
antibodies (Hycult) and secondary Alexa Fluor 594 antibodies (Invitrogen). Cells were 
visualised using a Zeiss Axioplan II microscope at x40 objective (Zeiss).  
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Ficolin binding assays 
Fixed A. fumigatus conidia were washed twice in ficolin binding buffer (FBB) (5.0 mM 
CaCl2, 155.0 mM NaCl, 25.0 mM HEPES, 0.5% BSA, 0.1% Triton X-100). A. fumigatus was 
then incubated with 18.4 μg mL−1 H-ficolin for 1 h at 37°C. Fungi were washed as described 
above, prior to antibody-labelling of the Aspergillus-H-ficolin complex with monoclonal 
mouse anti-H-ficolin antibodies (1:100; R&D Systems) for 30 min at 4°C. Following 
washing, the secondary antibody (goat anti-mouse Ig-fluorescein isothiocyanate [FITC]; 
Beckman Coulter, United Kingdom) at a 1:200 dilution was incubated with the complex for 
30 min at room temperature (RT). Following washing, the Aspergillus-ficolin complex was 
fixed with 4% PBS–formaldehyde for 10 min at RT, washed, and resuspended in sterile PBS. 
Calcium-dependent binding was investigated in FBB without calcium and in the presence of 
5 mM EGTA. For testing the influence of the pH on H-ficolin binding, the pH of FBB was 
adjusted with concentrated HCl or NaOH to generate a range of pH from pH 3.7 to 10.7. 
 
The carbohydrate-recognition characteristics of H-ficolin were determined using a ligand 
inhibition assay prior to Aspergillus binding. Concentrations (0.75, 3.1, 12.5, 25, 50, 100 
mM) of various carbohydrates (glucose, GlcNAc, galactose, N-acetylgalactosamine 
[GalNAc], L-fucose, D-mannose and N-acetylcysteine [CysNAc]) were incubated with 18.4 
μg mL−1 of H-ficolin for 2 h at RT. Following the ligand inhibition, the ficolin/sugar complex 
was then added to the Aspergillus spp. and analyzed for binding as described above. 
H-ficolin binding to conidia or hyphae was analyzed by flow cytometry (Detection was on 
the FL1-A detector channel: laser excitation, 488 nm; emission detection, 533/30 nm) using a 
BD Accuri C6 flow cytometer with BD CFlow software (BD Accuri Cytometers). 
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Fungal association assays 
Human A549 type II alveolar adenocarcinoma cells were seeded on 48-well plates (Nunc, 
United Kingdom) in supplemented RPMI 1640 and grown to semi-confluence at 37°C in a 
5% CO2 atmosphere. FITC-labelled fixed A. fumigatus conidia were opsonized with 18.4 μg 
mL−1 BSA or H-ficolin for 1 h at 37°C in FBB lacking Triton X-100. H-ficolin-opsonized A. 
fumigatus conidia (5 x 105) were incubated for 16 h with adherent A549 cells (ratio of conidia 
to cells of 5:1) at pH 5.7 or pH 7.4 at 37°C in a 5% CO2 atmosphere. Following incubation, 
non-adherent conidia and A549 cells were removed and the adherent cells were washed with 
warm supplemented RPMI 1640. Adherent cells were subsequently removed by the use of 
trypsin-EDTA and gentle trituration. Cells were pooled and fixed in 4% PBS–formaldehyde 
for 10 min at RT and analyzed by flow cytometry using a BD Accuri C6 flow cytometer with 
BD CFlow software. The percentage of A549 cells associated with FITC-positive A. 
fumigatus conidia was determined by gating on the A549 cell population (forward scatter 
channel/side scatter channel [FSC/SSC]) and calculating the percentage of A549 cells 
staining positive for fluorescence (FL1-A). 
 
Cytokine determination 
Supernatants were collected 24 h following A549 challenge with live A. fumigatus conidia. 
Cytokine production from supernatants was quantitated using a BD cytometric bead array 
(CBA) Human Inflammatory Cytokines kit (BD Biosciences). Assays were conducted as 
outlined in the protocol. In brief, capture beads for the measurement of IL-8, IL-1β, IL-6, IL-
10 and TNF-α were mixed together prior to their addition to the sample and standard tubes. 
Following the addition of capture beads to the samples, Human Inflammatory Cytokine PE 
Detection Reagent was added to all tubes and incubated for 3 h in the absence of light. 
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Following incubation, samples were washed in wash buffer for 5 min at 200 g prior to 
aspiration of the supernatant, re-suspension in wash buffer and flow cytometry (Exλ 488 nm, 
Emλ 585/40nm) and (Exλ 633 nm, Emλ 780/30 nm) on a BD Accuri C6 flow cytometer with 
BD CFlow® Software, collecting 1500 events as outlined in the protocol. 
To investigate the role of MAPK signalling in IL-8 production, inhibitors of MEK 1/2 
(U0126), p38 MAPK (SB202190) and JNK (SP600125) were added to cells at a 
concentration of 10 µM for 1 h prior to and during A. fumigatus challenge.  
 
Measurement of C3b deposition 
Endogenous ficolins were removed from donor serum by passing 5 mL through a 1 mL N-
acetyl-D-glucosamine column at 4°C overnight. Removal of ficolins from the serum was 
confirmed using a ficolin-3 human ELISA kit (Hycult). Ficolin-depleted serum was stored at 
-80°C until use.  
 
To measure lectin-pathway C3 deposition, 96-well Maxisorb plates (Nunc) were coated with 
fixed A. fumigatus conidial suspensions (OD550 of 0.5) or 5 µg mL-1 N-acetyl BSA in coating 
buffer (15 mM Na2CO3, 35 mM NaHCO3, pH 9.6) and incubated overnight at 4°C. Non-
specific proteins were then blocked with 1% (wt/vol) BSA-TBS for 2 h at RT. Once blocked, 
plates were washed three times with wash buffer (TBS, 0.05% Tween-20, 5 mM CaCl2, pH 
7.4). To quantify C3 deposition, 100 µL of ficolin-sufficient/deficient serum was added to the 
wells in barbital buffered saline (BBS; 4 mM barbital, 145 mM NaCl, 1 mM MgCl2, 2 mM 
CaCl2, pH 7.4). Ficolin-deficient serum was either reconstituted with recombinant H-ficolin 
(18.4 µg mL-1) or left ficolin-deficient for 1.5 h at 37°C. Plates were washed again three 
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times prior to the addition of primary antibody rabbit anti-human C3c (1:500; Dako) and 
incubated for 1.5 h at 37°C. Following three washes, the secondary antibody anti-rabbit 
alkaline phosphatase (1:5000; Sigma-Aldrich) was added and incubated for 1 h at RT. The 
assay was developed using p-nitrophenyl-phosphate (pNPP; Sigma-Aldrich) and absorbance 
was measured at 405 nm. N-acetyl BSA was used as a positive control.  
 
Statistical analysis  
Results were expressed as mean ± SD. Descriptive and 2-tailed Students t-test analyses were 
performed using GraphPad prism software (version 5). One-way ANOVA’s were performed 
using SigmaStat software (version 3.5).  A value of p<0.05 was considered statistically 
significant. Receiver operating characteristics (ROC) curve analysis was conducted using 
MedCalc (version 13.1.1).   
 
Results 
H-ficolin binds to A. fumigatus conidia. 
It has been acknowledged that H-ficolin is capable of binding A. fumigatus, albeit with low 
affinity 16. We further characterised this binding and showed that the recognition of A. 
fumigatus by H-ficolin occurred in a pH- and calcium-dependent manner and was inhibited 
by L-fucose, D-mannose and GlcNAc.  
H-ficolin is produced by type II alveolar epithelial cells15. However, it wasn’t established 
whether A549 cells; a widely used model for the type II alveolar epithelium, could also 
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produce H-ficolin. We made the observation that H-ficolin could be found within A549 cells 
(data not shown).  
We also demonstrated H-ficolin binding to A. fumigatus conidia. Following opsonization of 
fixed A. fumigatus conidia (5 x 105) with H-ficolin (18.4 µg mL-1), we observed significant 
binding (median fluorescence intensity of 632.5 ±21.0 versus 207.7 ±1.5 and 215.0 ±1.0 for 
H-ficolin opsonized conidia versus un-opsonized and BSA opsonized conidia, respectively; 
p=4.01 x 10-6, Fig. 1A and Fig. 1C).  
 
A characteristic of the related collectin family is the requirement of calcium to bind to their 
ligands 23. Therefore we investigated H-ficolin binding to conidia in the absence of 
extracellular calcium. When calcium was removed from the binding buffer and excess 
calcium was chelated by EGTA, H-ficolin binding was observed to significantly decrease to 
levels observed for the BSA control (median fluorescence intensity of 294.7 ±13.8 versus 
632.5 ±21.0 and 206.3 ±3.5 for H-ficolin opsonized conidia versus un-opsonized and BSA 
opsonized conidia, respectively; p=2.02 x 10-5, Fig. 1A and Fig. 1C). 
 
The pH is an important aspect of infection as it decreases at the local site of infection to as 
low as pH 5.5 24.  Therefore, it is vital that the functions of innate recognition proteins are 
enhanced during host infection. We had previously observed that binding of L-ficolin and its 
rodent orthologue, ficolin-A, to A. fumigatus was pH-dependent, occurring optimally at pH 
5.7 (Bidula et al., 2013; Bidula et al., 2015). Additionally, others had highlighted that pH 
could alter the confirmation of the FBG domain (Garlatti et al., 2007; Garlatti et al., 2007) 
therefore binding studies were conducted in a range of from pH 3.7 to pH 10.7.  
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Here, binding occurred in a pH-dependent manner, with maximal binding observed in acidic 
(pH 5.7) conditions. Binding at pH 5.7 was significantly greater than binding at pH 7.4 
(median fluorescence intensity of 632.5 ±21.0 versus 549.3 ±12.0 for H-ficolin opsonized 
conidia in pH 5.7 and pH 7.4 conditions, respectively; p=0.00398, Fig. 1D). However, 
binding at pH 7.4 was still significant (median fluorescence intensity of 549.3 ±12.0 versus 
207.6 ±1.5 for H-ficolin opsonized conidia versus un-opsonized conidia; p=1.09 x 10-6; Fig. 
1D).  
 
Ficolins recognise pathogens via carbohydrate moieties on their cell surface. Therefore, to 
investigate H-ficolin carbohydrate-binding specificity, H-ficolin was pre-incubated with a 
range of carbohydrates (glucose, galactose, GlcNAc, L-fucose and D-mannose) prior to 
incubation with A. fumigatus conidia. L-fucose, GlcNAc and D-mannose exhibited the 
greatest binding inhibition (% total inhibitions of 70.0% ±1.6%, 88.7% ±7.0% and 93.4% 
±7.0% at maximal carbohydrate concentration of 100 mM and IC50 of <0.75 mM, IC50 of 
<3.25 mM and IC50 of <3.25 mM for L-fucose, GlcNAc and D-mannose, respectively; Fig. 
1E). Conversely, pre-incubation with glucose and galactose led to significantly lower 
percentage inhibitions (% inhibitions of 15.5% ±1.5% and 24.8% ±10.5% at maximal 
carbohydrate concentration of 100 mM for glucose and galactose, respectively; Fig. 1E).  
 
H-ficolin opsonization enhances association of A.  fumigatus conidia with A549 cells.  
H-ficolin is secreted from type II pneumocytes 15 and can be found within A549 cells, which 
suggests it could be important in potentiating immune responses within the lung. 
Additionally, patients homozygous for a truncated form of H-ficolin exhibit a recurrence of 
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respiratory infections25. We were, therefore, interested in whether H-ficolin could modulate 
the association of A. fumigatus with the A549 airway epithelial cell line.  
To investigate the interaction of H-ficolin opsonised conidia with the alveolar epithelium, 
FITC-labelled, fixed A. fumigatus conidia were opsonized with H-ficolin prior to incubation 
with A549 cells for 16 hours in pH 5.7 or pH 7.4 conditions. A549 cells were gated (Fig. 2A) 
and the percentage of FITC negative and positive were used to identify associated cells (Fig. 
2B). There was a uniform shift in the fluorescence of the A549 population meaning that the 
majority of A549 cells were associated with conidia. However, in the presence of H-ficolin, 
the number of conidia associated per A549 cell was significantly increased (based upon the 
median fluorescence intensity) but only in inflammatory (pH 5.7) conditions (median 
fluorescence intensity of 313,045 ±77,970 versus 596,893 ±18,846 for un-opsonized and H-
ficolin opsonized conidia, respectively; p=0.00359, Fig. 2C). Furthermore, A. fumigatus were 
still capable of germinating within A549 cells regardless of H-ficolin opsonization (data not 
shown).  
 
H-ficolin opsonisation leads to lectin complement pathway C3b deposition on A.  
fumigatus conidia.  
Following the observation that H-ficolin could enhance host-fungal interactions, we explored 
potential mechanisms to explain this augmentation. One way in which ficolins could enhance 
this interaction was via the activation of the lectin complement pathway and deposition of 
C3b on the pathogen surface. C3b itself can contribute to enhanced phagocytosis of 
Aspergillus by functioning as an opsonin26.  However, whether H-ficolin could activate the 
lectin complement pathway on A. fumigatus and contribute to C3 deposition was unknown 8, 
27
. 
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To investigate H-ficolin activation of the lectin pathway on A. fumigatus conidia, human 
serum was either run through a GlcNAc-sepharose column to remove endogenous ficolins or 
left ficolin-sufficient. Following the removal of endogenous ficolins, there was significantly 
diminished C3 deposition on A. fumigatus (p<0.05) but ficolin-sufficient serum maintained 
maximal levels of C3 deposition (Fig. 3). Here we observed an EC50 of 1.15% serum versus 
an EC50 of 0.32% serum for ficolin-deficient and ficolin-sufficient serum, respectively (not 
shown). Moreover, reconstitution of the ficolin-deficient serum with recombinant H-ficolin 
was capable of significantly restoring the level of C3 deposition to normal levels (EC50 of 
0.34% serum; p<0.05; Fig. 3).  
 
Opsonization by H-ficolin increases IL-8 production from A549 cells after A. fumigatus 
challenge and involves the activation of the intracellular signalling pathways MEK 1/2, 
p38 MAPK and JNK. 
Previously, we have observed that another serum ficolin, ficolin-A is capable of modulating 
IL-8 production 10. Therefore, we utilised cytometric bead arrays to measure the 
concentration of IL-8, IL-1β, IL-6, IL-10 and TNF-α following challenge by H-ficolin 
opsonized live A. fumigatus conidia.  
 
From the cytokine panel tested, H-ficolin opsonization induced a significant increase in the 
secretion of pro-inflammatory IL-8 compared to challenge with un-opsonized conidia after 24 
h (IL-8 concentrations of 611.5 pg mL-1 ±56.1 versus 1893.3 pg mL-1 ±263 for un-opsonized 
and H-ficolin opsonized conidia, respectively; p=0.00117, Fig. 4A). H-ficolin in the absence 
of conidia induced an increase in IL-8 but this increase wasn’t statistically significant 
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(p=0.06725, Fig. 4A). All other measured cytokines were not significantly affected by H-
ficolin opsonization (data not shown).  
Based upon previous studies that showed that IL-8 secretion from respiratory cells following 
A. fumigatus challenge was governed by PI3K, p38 MAPK and ERK 1/2, we chose to inhibit 
key members within the MAPK signalling pathways 28. In order to investigate the 
intracellular signalling pathways involved in the increase of IL-8 secretion from A549 cells 
following challenge by H-ficolin opsonized A. fumigatus, we used the MEK 1/2 inhibitor 
U0126, the p38 MAPK inhibitor SB202190 and the JNK inhibitor SP600125 prior to the 
quantification of IL-8 by bead array. It was observed that MEK 1/2 inhibition completely 
abrogated IL-8 production following challenge with un-opsonized or H-ficolin-opsonized 
conidia (p<0.001, Fig. 4B). Inhibition of p38 MAPK and JNK also significantly reduced IL-8 
production both in the presence and absence of H-ficolin opsonization (p<0.001; Fig. 4B).  
The incremental increase of IL-8 from A549 cells that was induced by H-ficolin alone in the 
absence of A. fumigatus also appeared to be significantly reduced via inhibition of MEK 1/2 
and JNK but less so by the p38 MAPK inhibitor SB202190 (p<0.001, Fig. 4B). 
 
Raised H-ficolin concentrations in the bronchoalveolar lavage fluid of lung transplant 
recipients displaying signs of post-transplant pneumonia.  
H-ficolin can be secreted into the BAL fluid from bronchial epithelial cells and alveolar type 
II epithelial cells; therefore, we chose to investigate the concentration of H-ficolin in the BAL 
fluid from transplant patients (a high risk group for invasive aspergillosis) with or without 
signs of lung infection.  
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Here, we utilised an H-ficolin-specific ELISA to detect the presence of H-ficolin in the BAL 
samples of lung transplant recipients. H-ficolin was observed to be present in both the lungs 
of healthy and infected transplant recipients. However, in patients who were diagnosed with 
invasive pulmonary fungal infection based on EORTC/MSG criteria and/or positive 
GM/lateral-flow, bacterial or viral infection, H-ficolin BAL concentration was significantly 
higher compared to healthy recipients (p=0.00726; Fig. 5A). Out of the 16 infected lung 
transplant patients, one was infected with Penicillium spp., one with Staphylococcus aureus, 
one with rhinovirus, three with Pseudomonas aeruginosa, four with A. fumigatus and six 
without detectable cultures but with radiology suggestive of fungal infection or positive GM 
and/or lateral flow test. Within these groups, patients infected with A. fumigatus had 
consistently higher concentrations of H-ficolin in the BAL (average concentration of 19.4 ng 
mL-1; Fig. 5B). The one patient with rhinovirus had a higher BAL H-ficolin concentration 
(average concentration of 24.1 ng mL-1) but this was only data from one patient (Fig. 5B). An 
ROC curve analysis was conducted to investigate whether the detection of H-ficolin could be 
used as a potential biomarker/diagnostic tool for lung infection. The area under the curve 
(AUC) was calculated to be 0.77 which suggested there was an 77% chance that infected 
transplant patients would have H-ficolin present in their BAL fluid (p<0.0001; Fig. 5C).  
 
Discussion 
In this study, we focused on the role of H-ficolin in the innate immune recognition of A. 
fumigatus and its role in host-fungal interactions. This work led to a number of new 
observations. Firstly, H-ficolin was capable of recognising A. fumigatus conidia in a calcium-
dependent and pH-dependent manner, in an interaction inhibited by D-mannose, L-fucose 
and GlcNAc. This recognition also led to enhanced host-microbe interactions. Secondly, H-
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ficolin opsonization led to activation of complement on A. fumigatus. Thirdly, in the presence 
of H-ficolin, we observed an increase in the production of IL-8 which was abrogated 
following inhibition of MEK 1/2, p38 MAPK and JNK. Finally, H-ficolin concentration in 
the BAL fluid was greater in transplant recipients with post-transplant lung infections 
compared to uninfected control patients.  
 
This work has, therefore, led us to postulate that as part of an anti-fungal inflammatory 
response, H-ficolin concentrations are increased in the lung environment. Moreover, H-
ficolin recognizes conidia via its cell surface glycoproteins and enhances the immune 
function of lung epithelial cells in the defence against A. fumigatus.  
 
To date, all of the serum ficolins had been observed to be capable of binding to A. fumigatus 
conidia but of these serum ficolins, H-ficolin binding was least characterized10, 16, 29. We 
therefore proceeded to characterize the manner in which H-ficolin recognised A. fumigatus 
conidia. H-ficolin was observed to significantly bind to conidia, albeit much less avidly than 
serum L-ficolin or its rodent orthologue, ficolin-A. This could be explained by H-ficolin’s 
much lower affinity for GlcNAc compared to L-ficolin. Similarly to L-ficolin and the related 
collectins, MBL and the surfactant proteins, H-ficolin binding to A. fumigatus also required 
the presence of calcium 30, 31. 
 
Ficolins are capable of distinguishing between self and non-self carbohydrates on pathogenic 
microorganisms via their FBGs 32 and we can identify their specificity for carbohydrates in 
the pathogen cell wall via competitive inhibition of their FBG. Few studies to date have 
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highlighted the carbohydrate recognition properties of H-ficolin, with binding previously 
only observed to a polysaccharide of Aerococcus viridians, acetylated carbohydrates and very 
few pathogens 16, 33, 34. The cell wall of A. fumigatus is predominantly composed of glucan, 
chitin and galactomannan and it is these cell wall glycoproteins that constitute the Aspergillus 
virulence factors 35. When further deconstructed, the wall is composed of glucose, 
glucosamine, galactose and mannose 7, 36. In the present study, we indicate novel binding 
targets for H-ficolin in the shape of D-mannose and L-fucose while re-establishing the 
preference of ficolin binding to GlcNAc. Interestingly, neither D-mannose nor L-fucose was 
able to inhibit binding of H-ficolin in previous studies but these inhibition studies were not 
conducted at varying pH 34. This data implies that H-ficolin recognises its targets via multiple 
binding sites on the fibrinogen-like domain with additional sites for mannose and/or fucose as 
well as separate sites for GlcNAc. All in all, the binding of H-ficolin to a range of 
carbohydrate structures on the conidial surface is essential for efficient pathogen recognition. 
This could have the potential to influence Aspergillus infection via restricting fungal adhesion 
and masking inflammation induced by surface virulence factors. However, those fungi 
evading immune recognition can provoke an inflammatory response and lead to tissue 
necrosis, acidifying the local pH.  
 
Based upon our previous observations whereby ficolin-A binding to A. fumigatus was 
dependent upon the pH in addition to studies characterising H-ficolin 10, 34, we have shown 
that the affinity of H-ficolin for A. fumigatus is also significantly enhanced in an acidic pH. 
The pH is an important aspect of infection as it decreases at the local site of infection to as 
low as pH 5.5 24. Our findings support that the acidic conditions found in inflammatory sites 
could be capable of potentiating the opsonization of A. fumigatus by H-ficolin.  
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One of the key biological consequences of opsonization is the enhancement of uptake by host 
cells. Conidia are very small structures (2-4 µm in size) and because of this, they can 
penetrate deep into the alveolar space where they encounter the first line of defence in the 
shape of type II pneumocytes 37. The important role of ficolins in the enhancement of host-
microbe interactions is well documented. We have previously shown that L-ficolin and 
ficolin-A can function as opsonins and enhance association of A. fumigatus and the clinically 
relevant yeast, Cryptococcus neoformans with host cells10, 38. Our current study indicates that 
H-ficolin is also capable of significantly increasing the association of conidia with A549 cells 
in comparison to un-opsonized or BSA-opsonized controls, suggesting an important role for 
H-ficolin in immobilising the fungus following inhalation.  
 
One such immune mechanism that can lead to enhanced interactions is the activation of 
complement. Complement activation can lead to the deposition of C3b, which, like H-ficolin, 
also functions as an opsonin 26. Ficolins are able to activate the lectin complement pathway 
following the association with MASPs. Therefore, we investigated whether H-ficolin could 
contribute to complement activation on A. fumigatus. Following the depletion of ficolins from 
the serum we still observed some C3b deposition. This is likely due to complement activation 
by the residual MBL and/or collectin-11 (CL-11) that was not removed by the depletion 
method. However, following reconstitution of ficolin depleted human serum with 
recombinant H-ficolin, we observed a restoration of C3b deposition to normal levels. 
Previous observations by Ma et al 29 demonstrated a lack of H-ficolin binding to a clinical 
sample of A. fumigatus and, thus, no complement activation. However, recognition and 
lectin-pathway activation may be species and strain specific, as highlighted for Pseudomonas 
aeruginosa 39. Therefore, future studies with a range of established strains may be necessary 
to further illuminate the role of H-ficolin in lectin complement pathway activation.  
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Recent advances in the field have highlighted novel functions of ficolin-A, L-ficolin and M-
ficolin in the immunomodulation of cytokines 10-12, 14. Whether this could also be achieved 
following H-ficolin opsonization was previously unknown.  Indeed, as identified previously 
for ficolin-A 10, we observed potentiation of IL-8 production following A549 cell challenge 
with H-ficolin opsonized conidia. IL-8 is crucial in the recruitment of neutrophils during 
aspergillosis, which play a key role in A. fumigatus infection 40. A. fumigatus itself is not a 
strong stimulator of IL-8 production from the A549 cell line and dampening of the immune 
response could be a potential immune evasion mechanism 41. Therefore, we postulated that 
H-ficolin performs an important role in the enhancement of the immune response and could 
be important in immune responses, such as neutrophil recruitment.  Unlike its serum 
counterparts, ficolin-A and L-ficolin, H-ficolin in the absence of A. fumigatus did not 
significantly enhance IL-8 production. As H-ficolin is produced directly in the lung, it would 
not be beneficial for it to increase inflammation in the absence of pathogen challenge; as 
excess inflammation is detrimental to normal lung function 10.  
 
The mechanisms underlying this increase were, and still are, poorly understood, as cell 
surface receptors for the serum ficolins and signalling pathways involved are unknown. 
Therefore, we aimed to delineate some of the signalling pathways that may be involved. 
Following inhibition of the ERK 1/2 activator, MEK 1/2, by the highly potent inhibitor 
U0126, inhibition of p38 MAPK by SB202190 and inhibition of JNK by SP600125, we 
observed almost complete abrogation of IL-8 production following A549 cell challenge with 
H-ficolin opsonized conidia. Of these, MEK 1/2 inhibition appeared to lead to the greatest 
inhibition. The ERK 1/2 pathway has been demonstrated to be important for IL-8 synthesis 
following challenge by pathogens and elucidating how H-ficolin activates this pathway could 
prove important in the understanding of its immunomodulatory function 28, 42, 43. Due to their 
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importance in fungal immunity, potential cell surface receptor targets include TLRs and C-
type lectin-like receptors of the dectin-1 cluster 44-48, but the signalling mechanisms involved 
require much greater investigation.   
 
In addition to the in vitro studies, we were interested if in vivo observations could highlight 
an important role for H-ficolin during lung infections. To investigate this, we took lung 
transplant patients (a high risk group for invasive aspergillosis) and measured the 
concentration of H-ficolin in their BAL fluid. H-ficolin is normally secreted into the BAL 
fluid of healthy lungs regardless of infection but there were significantly higher 
concentrations of H-ficolin in the BAL of lung transplant recipients diagnosed with post-
transplant pneumonia compared to healthy recipients. Interestingly, the average BAL H-
ficolin concentration was highest in the patients who were infected with A. fumigatus but the 
absolute concentration of H-ficolin in the lung is difficult to quantify due to the variability of 
dilution factors during bronchoscopy. Recent in vivo observations have acknowledged that 
serum ficolins could play an important role in lung defence against pathogenic 
microorganisms, with serum L-ficolin present in the lung only during fungal infection 14 and 
truncated forms of H-ficolin increasing susceptibility to respiratory infections 25. Although 
the current sample size is small (32 patients), ROC analysis has indicated that the presence of 
H-ficolin in the lungs of transplant patients could be a potential human diagnostic biomarker 
for infection and in combination with fungal specific markers such as galactomannan, may be 
used in the diagnosis of fungal infection. However, this diagnostic potential will need to be 
further investigated in larger clinical trials.  
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In conclusion, H-ficolin may play a significant role in the defence against A. fumigatus via 
the activation of the lectin complement pathway, enhanced host-microbe interactions and 
modulation of the immune response. Yet, the use of the A549 cell line is a limitation to the 
current study and further investigation using primary airway epithelial cells could yield 
important observations.  
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Figures legends 
Figure 1. Binding characteristics of H-ficolin to A. fumigatus conidia. H-ficolin (18.4 µg 
mL-1) was incubated with 5 x 105 conidia in the presence or absence of calcium, a range of 
pHs from pH 3.7-10.7 or following pre-incubation with a variety of carbohydrates. (A) 
Representative histogram of H-ficolin binding to A. fumigatus conidia in the presence of 
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calcium. (B) Representative histogram of H-ficolin binding to A. fumigatus conidia in the 
absence of calcium. (C) Binding of H-ficolin to A. fumigatus conidia in the presence and 
absence of calcium indicating the median fluorescence intensity (MFI). (D) Binding of H-
ficolin to A. fumigatus conidia in a range of pHs from pH 3.7- pH 10.7. (E) Carbohydrate 
binding specificity of H-ficolin to A. fumigatus conidia. H-ficolin was pre-incubated with a 
range of carbohydrates (glucose, galactose, L-fucose, D-mannose and GlcNAc) at various 
concentrations (0-100 mM) prior to conidial binding at pH 5.7.  Results are representative of 
the average of all the data points gained from three independent experiments. Error bars 
represent the SD and significance was determined via two-tailed Students t-test. For 
carbohyrdrate inhibitions, significance was determined via one-way ANOVA and post-hoc 
analysis was conducted using the Tukey test. An asterisk indicates a significant difference 
(p<0.05). 
 
Figure 2. H-ficolin opsonization enhances association of A. fumigatus conidia with A549 
epithelial cells. FITC-labelled A. fumigatus conidia (5 x 105) were opsonized with 18.4 µg 
mL-1 H-ficolin prior to incubation with A549 cells (conidia:A549 ratio of 5:1) in pH 5.7 and 
pH 7.4 conditions for 16 h. (A) P1 gate on the A549 population. (B) Representative 
histogram depicting the fluorescence (FL1-A) of the A549 population following challenge 
with un-opsonized or H-ficolin opsonized A. fumigatus conidia. (C) The relative number of 
associated FITC-labelled conidia (based upon the median fluorescence intensity (MFI) either 
un-opsonized (- H-ficolin), BSA-opsonized (+ BSA) or H-ficolin opsonized (+ H-ficolin). 
Results are representative of the average of all the data points gained from three independent 
experiments. Error bars represent the SD and significance was determined via two-tailed 
Students t-test. An asterisk indicates a significant difference (*p<0.05).  
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Figure 3. H-ficolin activates the lectin complement pathway on A. fumigatus conidia. 
The restoration of lectin complement pathway C3 deposition was observed on A. fumigatus 
following the reconstitution of ficolin-depleted human serum with recombinant H-ficolin. 
Serum dilutions of serum were incubated in Maxisorb microtiter 96-well coated plates and 
deposited C3 was detected by using rabbit anti-human C3c complement antibodies and goat 
anti-rabbit IgG-alkaline phosphatase conjugate. N-acetyl BSA was used as a positive control 
for C3 deposition (*p<0.05). HS = human serum; HF = H-ficolin; AF = A. fumigatus; NBSA 
= N-acetyl BSA; rHF = recombinant H-ficolin. All data points are represented as mean 
absorbance measured at 405 nm in the presence of 1.25% serum and are representative of the 
data obtained from three independent experiments. Significance was determined via one-way 
ANOVA and post-hoc analysis was determined using the Tukey test.  
 
Figure 4.  IL-8 secretion from A549 epithelial cells is enhanced following challenge with 
H-ficolin opsonized A. fumigatus conidia and is reliant upon MEK 1/2, p38 MAPK and 
JNK activation. (A) Supernatants from A549 cells were collected 24 h after challenge with 
H-ficolin (18.4 µg mL-1) alone, conidia (1 x 106) alone or H-ficolin (18.4 µg mL-1)-opsonized 
A. fumigatus (1 x 106 conidia), prior to cytometric bead array. (B) To investigate the cell 
signalling pathways involved, A549 cells were pre-incubated with 10 µM of the MEK 1/2 
inhibitor (U0126), the p38 MAPK inhibitor (SB202190) or the JNK inhibitor (SP600125) 
prior to A. fumigatus challenge. Media from A549 cells without stimulus and LPS (100 ng 
mL-1; grey bar) were used as negative and positive controls, respectively. DMSO was used as 
a vehicle control for MAPK inhibitors (white bar). All data are represented as the average 
concentration of IL-8 produced (pg mL-1) and are representative of the averages of all the 
data points gained from three independent experiments. Error bars represent the SD. 
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Significance was determined via two-tailed Students t-test. An asterisk indicates a significant 
difference (*p<0.05). 
 
Figure 5. BAL H-ficolin concentrations from infected lung transplant patients are 
higher than those found in non-infected patients. BAL fluid was collected following 
bronchoscopies on lung transplant patients prior to the measurement of H-ficolin 
concentrations by ELISA. (A) The concentration of H-ficolin (ng mL-1) in BAL samples.  
BAL samples were considered positive (n=16) or negative (n=16) for infection dependent 
upon patients classification according to EORTC/MSG criteria, Aspergillus antigen detection, 
radiology and bacterial, viral or fungal cultures. (B) H-ficolin concentration in the BAL fluid 
of patients testing culture positive for Penicillium (Pen; n=1), P. aeuriginosa (PsA; n=3), A. 
fumigatus (AsF; n=4), S. aureus (StA; n=1), rhinovirus (Rhi; n=1) or culture negative (Nil; 
n=6). (C) ROC curve analysis for H-ficolin detection in infected transplant patients compared 
to non-infected transplant patients. Results are representative of the data points gained from 
three independent experiments (16 positive and 16 negative patients). Bars represent the 
median and significance was determined via two-tailed Students t-test. An asterisk indicates a 
significant difference (*p<0.05). 
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